Medicaid Emergency Authority Tracker: Approved State Actions to Address COVID-19

Published: Jul 1, 2021

During the COVID-19 Public Health Emergency, states used a number of Medicaid emergency authorities to address the coronavirus emergency. Between March 2020 and July 2021 we tracked details on Medicaid Disaster Relief State Plan Amendments (SPAs), other Medicaid and CHIP SPAs, and other state-reported administrative actions; Section 1115 Waivers; Section 1135 Waivers; and 1915 (c) Waiver Appendix K strategies. This page aggregates tracking information on approved Medicaid emergency authorities. This page was last updated July 1, 2021 and is no longer being updated.

Contents of Tracker:

Visit our State Data and Policy Actions COVID-19 Tracker for additional data on state responses to COVID-19, and our special coronavirus topic page for all our resources.

Approved Medicaid Emergency Authorities as of July 1, 2021

(back to top)

>

 

 

Medicaid and CHIP State Plan Amendments and Other State-Reported Administrative Actions to Address COVID-19: This table summarizes changes approved through Medicaid Disaster Relief SPAs and other Medicaid and CHIP SPAs based on approvals posted to Medicaid.gov, and also includes information on state-reported administrative actions to respond to COVID-19 based on review of state Medicaid agency and other state-level websites. CMS provided a template for states to request approval of Medicaid Disaster Relief State Plan Amendments (SPAs) related to the COVID-19 National Emergency. The Disaster Relief SPA allows states to make temporary changes to their Medicaid state plans and address access and coverage issues during the COVID-19 emergency. States can also make changes through traditional SPAs and can implement changes under existing authority that do not require SPA approval. (Note that some state-reported actions may require and/or are pending SPA approval.) Data under the “Telehealth” header are provided by Manatt Health (for more information see notes below the table). While this table captures state-reported actions taken in response to the COVID-19 emergency, there is considerable variation across states and states may have adopted policy options prior to the emergency that are not reflected here.

 

 

SPA and Other Administrative Actions to Address COVID-19 as of July 1, 2021

(back to top)

>

 

Section 1115 Waivers to Address COVID-19: In response to the COVID-19 public health emergency, CMS developed a new Medicaid Section 1115 demonstration opportunity and application template. These demonstrations can be used to extend HCBS flexibilities available under 1915 (c) home and community-based services waiver Appendix K (separately detailed in this tracker) to beneficiaries receiving long-term services and supports (LTSS) under SPA authorities (such as 1915 (i) state plan HCBS and 1915 (k) Community First Choice) and to allow for applicant self-attestation of resources for the purpose of determining eligibility for certain groups. States must complete a final monitoring and evaluation report one year after the demonstration ends. These demonstrations could be retroactive to March 1, 2020 and will expire no later than 60 days after the end of the public health emergency.

 

 

Approved Section 1115 Waivers to Address COVID-19 as of July 1, 2021

(back to top)

>

 

Section 1135 Waivers to Address COVID-19: If the President has declared an emergency or disaster and the Secretary of Health and Human Services (HHS) has declared a public health emergency, the Secretary can use Section 1135 authority to waive or modify certain Medicare, Medicaid, and CHIP requirements to ensure that sufficient health care items and services are available to meet the needs of Medicaid enrollees in affected areas. On March 13, 2020, President Trump issued a proclamation that the COVID-19 outbreak in the United States constitutes a national emergency, beginning March 1, 2020.  After this declaration, the Center for Medicare and Medicaid Services (CMS) issued blanket Section 1135 waivers for many Medicare provisions. Additionally, states were able to submit to CMS for approval Section 1135 waivers for Medicaid provisions. These approved state waivers are summarized in the table below.

 

 

Approved Section 1135 Waivers to Address COVID-19 as of July 1, 2021

(back to top)

>

 

Section 1915 (c) Waiver Appendix K Strategies to Address COVID-19: Most Medicaid home and community-based services (HCBS) are provided through Section 1915 (c) waivers. Other states use Section 1115 to authorize HCBS that could have been provided under Section 1915 (c). The table below includes Appendix K approvals for both 1915 (c) and 1115 HCBS waivers. States can use Section 1915 (c) waiver Appendix K to amend either of these HCBS waivers to respond to an emergency. For example, states can modify or expand HCBS eligibility or services, modify or suspend service planning and delivery requirements, and adopt policies to support providers. CMS posted a sample Appendix K template for COVID-19 for COVID-19 waiver amendment requests. Per updated guidance in December 2020, CMS may extend emergency authorities adopted under Appendix K through up to six months after the public health emergency ends.

 

 

Approved Section 1915 (c) Waiver Appendix K Strategies to Address COVID-19 as of July 1, 2021

(back to top)

>

Intersection of State Abortion Policy and Clinical Practice: June 2021 Update

Published: Jul 1, 2021

This infographic updates a prior JAMA infographic that presents state policies related to abortion and their intersection with clinical practice. The graphic highlights state-level abortion specific policies, ranging from waiting period laws to medication abortion requirements.

These charts highlight the 24% decrease in the abortion rate between 2009 to 2018, the 18 states that have jail sentences for providers that perform abortions beyond their state’s gestational limit, and the many states that restrict abortion access by placing limits on the provision of medication abortion, banning insurance coverage of abortion in private and Medicaid plans, and enforcing policies such as waiting periods, and requiring patients to be counseled on topics about abortion harms that are unsupported by medical evidence.

View Source Slides

House Appropriations Committee Releases the FY22 State and Foreign Operations (SFOPs) Appropriations Bill

Published: Jun 30, 2021

The House Committee on Appropriations released its FY 2022 State, Foreign Operations, and Related Programs (SFOPs) appropriations bill on June 28, 2021 and accompanying report on June 30, 2021. The SFOPs bill includes funding for U.S. global health programs at the State Department and the U.S. Agency for International Development (USAID). Funding for these programs, through the Global Health Programs (GHP) account, which represents the bulk of global health assistance, totaled $10.6 billion, an increase of $1.4 billion (16%) above the FY 2021 enacted level and $591 million (6%) above President Biden’s FY 2022 request, which was released on May 28, 2021. The bill provides higher levels of funding for almost all program areas compared to both the FY 2021 enacted level and the FY 2022 request, with global health security receiving most of the increase. Key highlights are as follows (Unless otherwise specified, funding comparisons are for the GHP account only. See Table for additional detail on global health funding):

  • Funding for global health security totals $1 billion, an increase of $810 million (426%) above the FY 2021 enacted level ($190 million) and $95 million (10%) above the FY 2022 request ($905 million).
  • Bilateral HIV funding through the President’s Emergency Plan for AIDS Relief (PEPFAR) is $4,850 million ($4,520 million through State and $330 million through USAID), $150 million (3%) above the FY 2021 enacted level and FY 2022 request.
  • The House bill includes $1,560 million for the U.S. contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), matching the FY 2021 enacted level and FY 2022 request. The Global Fund was the only area that did not increase.
  • Funding for tuberculosis (TB) totals $469 million, $150 million (3%) above the FY 2021 enacted level and FY 2022 request ($319 million).
  • Funding for malaria totals $820 million, $50 million (6%) above the FY 2021 enacted level and FY 2022 request ($770 million).
  • The House bill includes $880 million for maternal and child health (MCH), $24.5 million (3%) above the FY 2021 enacted level ($865.5 million) and essentially matching the FY 2022 request ($879.5 million). Specific areas under MCH include:
    • Gavi, the Vaccine Alliance funding totals $290 million, matching the FY 2021 enacted and FY 2022 request levels.
    • Polio funding totals $65 million, matching the FY 2021 enacted level. The President’s FY 2022 request did not specify funding for polio.
    • Funding for the U.S. contribution to the United Nations Children’s Fund (UNICEF) provided through the International Organizations and Programs (IO&P) account totals $139 million, matching the FY 2021 enacted level and FY 2022 request.
  • Funding for nutrition totals $160 million, $10 million (7%) above the FY 2021 enacted level and FY 2022 request ($150 million).
  • Bilateral family planning and reproductive health (FP/RH) funding totals $760 million in the House FY22 SFOPs bill, all of which is provided through the GHP account. This amount is $185 million (32%) above the FY 2021 enacted level ($575 million, of which $524 million is through the GHP account and $51 million is through the ESF account) and $176 million (30%) above the FY 2022 request ($584 million, of which $550 million is through the GHP account and $33.7 million is through the ESF account).
  • Funding for the United Nations Population Fund (UNFPA) totals $70 million, $37.5 million (115%) above the FY 2021 enacted level ($32.5 million) and $14 million (25%) above the FY 2022 request. The House FY 2022 bill notes that if this funding is not provided to UNFPA it “shall be transferred to the ‘Global Health Programs’ account and shall be made available for family planning, maternal, and reproductive health activities.”
  • Funding for the vulnerable children program totals $30 million, $5 million (20%) above the FY 2021 enacted level and FY 2022 request ($25 million).
  • Funding for neglected tropical diseases (NTDs) totals $112.5 million, $10 million (10%) above the FY 2021 enacted level and FY 2022 request ($102.5 million).
  • The House bill states that up to $90 million may be made available through the GHP account for the Emergency Reserve Fund, a mechanism that is used to quickly respond to emerging infectious disease outbreaks. The FY 2022 request provided $90 million for the Emergency Reserve Fund through the GHP account.

The SFOPs bill also includes the following policy provisions:

  • Removes the Helms amendment restrictions, which prohibit the use of foreign assistance to pay for the performance of abortion as a method of family planning or to motivate or coerce any person to practice abortion (see KFF fact sheet on major statutory requirements and policies pertaining to U.S. global FP/RH efforts here).
  • Repeals the Mexico City Policy (see KFF explainer here).
  • Provides the authority to transfer an amount “not to exceed an aggregate total of $200,000,000 of the funds appropriated by this Act” for international infectious disease outbreaks.
  • States that an unspecified amount of funding from the GHP account “may be made available for a contribution to an international financing mechanism for pandemic preparedness.”

Resources:

  • House FY 2022 State, Foreign Operations, and Related Programs (SFOPs) Appropriations Bill – Text
  • House FY 2022 State, Foreign Operations, and Related Programs (SFOPs) Appropriations Bill – Report

The Table (.xls) below compares global health funding in the FY 2022 House bill to the FY 2021 enacted funding amounts as outlined in the “Consolidated Appropriations Act, 2021” (P.L. 116-260; KFF summary here) and the FY 2022 request (KFF summary here).

See the KFF budget tracker for details on historical annual appropriations for global health programs.

Note: Some funding amounts (e.g. global health funding provided through the Economic Support Fund account at USAID) will be determined at the agency level, and are not earmarked by Congress in the SFOPs appropriations bill.

Table: KFF Analysis of FY22 House Appropriations for Global Health
Department / Agency / AreaFY21Enactedi(millions)FY22Request(millions)FY22Houseii(millions)Difference(millions)
FY22 House– FY21 EnactedFY22 House– FY22 Request
State, Foreign Operations, and Related Programs (SFOPs) – Global Health
HIV/AIDS$4,700.0$4,700.0$4,850.0$150 (3%)$150 (3%)
State Department$4,370.0$4,370.0$4,520.0$150(3%)$150(3%)
USAID$330.0$330.0$330.0$0(0%)$0(0%)
of which Microbicides$45.0$45.0$45.0$0(0%)$0(0%)
Global Fund$1,560.0$1,560.0$1,560.0$0 (0%)$0 (0%)
Tuberculosisiii$321.0 – –
Global Health Programs (GHP) account$319.0$319.0$469.0$150(47%)$150(47%)
Economic Support Fund (ESF) accountNot specified$2.0Not specified – –
Malaria$770.0$770.0$820.0$50 (6%)$50 (6%)
Maternal & Child Health (MCH)iv$1,039.5 – –
GHP account$855.5$879.5$880.0$24.5(3%)$0.5(<1%)
of which Gaviv$290.0$290.0$290.0$0(0%)$0(0%)
of which Polio$65.0$65.0$65.0$0(0%)$0(0%)
UNICEFvi$139.0$139.0$139.0$0(0%)$0(0%)
ESF accountNot specified$21.0Not specified – –
of which PolioNot specified$0.0Not specified – –
Nutritionvii$154.8 – –
GHP account$150.0$150.0$160.0$10(7%)$10(7%)
ESF accountNot specified$4.0Not specified – –
AEECA accountNot specified$0.8Not specified – –
Family Planning & Reproductive Health (FP/RH)viii$607.5$639.7$830.0$222.5 (37%)$190.3 (30%)
Bilateral FP/RHviii$575.0$583.7$760.0$185(32%)$176.3(30%)
GHP accountviii$524.0$550.0$760.0$236(45%)$210(38%)
ESF accountviii$51.1$33.7Not specified – –
UNFPAix$32.5$56.0$70.0$37.5(115%)$14(25%)
Vulnerable Children$25.0$25.0$30.0$5 (20%)$5 (20%)
Neglected Tropical Diseases (NTDs)$102.5$102.5$112.5$10 (10%)$10 (10%)
Global Health Security –$913.3 – – –
GHP account$190.0$905.0$1,000.0$810(426%)$95(10%)
USAID GHP accountx$190.0$655.0$1,000.0$810(426%)$345(53%)
State GHP accountxi –$250.0 – –
ESF accountNot specified$8.3Not specified – –
Emergency Reserve Fundxii$90.0xii – –
SFOPs Total (GHP account only)$9,196.0$10,051.0$10,641.5$1,445.5 (16%)$590.5 (6%)
Notes:
i – The FY21 final bill includes a provision giving the Secretary of State the ability to transfer up to $200,000,000 from the ‘Global Health Programs’, ‘Development Assistance’, ‘International Disaster Assistance’, ‘Complex Crises Fund’, ‘Economic Support Fund’, ‘Democracy Fund’, ‘Assistance for Europe, Eurasia and Central Asia’, ‘Migration and Refugee Assistance’, and ‘Millennium Challenge Corporation’ accounts “to respond to a Public Health Emergency of International Concern.”
ii – The FY22 House SFOPs bill provides the authority to transfer an amount “not to exceed an aggregate total of $200,000,000 of the funds appropriated by this Act” for international infectious disease outbreaks. The FY22 House SFOPs bill states that an unspecified amount of funding from the GHP account “may be made available for a contribution to an international financing mechanism for pandemic preparedness.”
iii – Some tuberculosis funding is provided under the ESF account, which is not earmarked by Congress in the annual appropriations bills and determined at the agency level (e.g. in FY19, TB funding under the ESF account totaled $3.6 million).
iv – Some MCH funding is provided under the ESF account, which is not earmarked by Congress in the annual appropriations bills and determined at the agency level (e.g. in FY19, MCH funding under the ESF account totaled $14.42 million).
v – The FY21 final bill text provides additional funding to Gavi to support coronavirus response efforts, stating, “For an additional amount for ‘Global Health Programs’, $4,000,000,000, to remain available until September 30, 2022, to prevent, prepare for, and respond to coronavirus, including for vaccine procurement and delivery: Provided, That such funds shall be administered by the Administrator of the United States Agency for International Development and shall be made available as a contribution to the GAVI, Alliance.”
vi – UNICEF funding in the FY21 final bill and FY22 House bill includes an earmark of $5 million for programs addressing female genital mutilation.
vii – Some nutrition funding is provided under the ESF account, which is not earmarked by Congress in the annual appropriations bills and determined at the agency level. (e.g. in FY17, nutrition funding under the ESF account totaled $21 million).
viii – The FY21 final bill states that “not less than $575,000,000 should be made available for family planning/reproductive health.” The FY22 request funding amounts are based on a bilateral total of $583.7 million as specified in the FY22 OMB Budget Appendices for the Department of State and Other International Programs. The FY22 House SFOPs bill text states that “not less than $760,000,000 shall be made available for family planning/reproductive health.” According to the FY22 House SFOPs bill report, $760 million is provided through the GHP account; however, it is possible that the administration could provide additional funding for FPRH activities through the ESF account.
ix – The FY21 final bill and FY22 House SFOPs bill texts state that if this funding is not provided to UNFPA it “shall be transferred to the ‘Global Health Programs’ account and shall be made available for family planning, maternal, and reproductive health activities.”
x – According to the Department of State, Foreign Operations, and Related Programs FY22 Congressional Budget Justification, $300 million of this funding is “for contributions to support multilateral initiatives leading the global COVID response through the Act-Accelerator platform.”
xi – According to the Department of State, Foreign Operations, and Related Programs FY22 Congressional Budget Justification, this funding is “to support a new health security financing mechanism, which would be developed alongside U.S. partners and allies, to ensure global readiness to respond to the next outbreak.”
xii – The FY21 final bill states that “up to $50,000,000 of the funds made available under the heading ‘Global Health Programs’ may be made available for the Emergency Reserve Fund.” The FY22 House SFOPs bill text states that “up to $90,000,000 of the funds made available under the heading ‘Global Health Programs’ may be made available for the Emergency Reserve Fund.”

The Status of Medicaid Expansion in Missouri and Implications for Coverage and Cost

Authors: Madeline Guth, Rachel Garfield, Robin Rudowitz, and Anthony Damico
Published: Jun 30, 2021

On June 23, 2021, a circuit court decision in Missouri put the state’s expansion of Medicaid under the Affordable Care Act (ACA) in limbo. Though a successful 2020 state ballot measure directed the expansion to be in effect by July 1, 2021, the legislature excluded expanded coverage from its fiscal year (FY) 2022 budget and the circuit court judge held that the state was not required to implement expansion. This decision, if upheld, has implications for coverage in the state as well as the availability of federal financing to cover the cost.

Figure 1: What is the status of Medicaid expansion in Missouri?

While expansion passed in Missouri through ballot initiative, the governor has since said that the state will not expand Medicaid because the legislature did not include expansion in its FY 2022 budget (Figure 1). On August 4, 2020, Missouri voters approved a ballot measure that added Medicaid expansion to the state’s constitution and required implementation of expansion coverage by July 1, 2021. Language in the constitutional amendment prohibits the imposition of additional burdens or restrictions on eligibility or enrollment for the expansion population (such as work requirements or premiums). In early 2021, Republican Governor Mike Parson included expansion in his proposed FY 2022 budget and the state submitted a State Plan Amendment (SPA) to CMS to implement expansion beginning July 1, 2021. In May, however, Governor Parson announced that the state’s Department of Social Services (DSS) was withdrawing its SPA submission and would not implement expansion as scheduled due to a lack of funding: the ballot measure did not include a revenue source and the Republican-controlled state legislature excluded the program from its final FY 2022 budget. Although advocates subsequently filed a lawsuit in state circuit county court against the DSS, in June a judge ruled that DSS’ refusal to expand Medicaid is lawful because the ballot initiative violated the state constitution by failing to provide a funding source. The plaintiffs appealed this decision and the state Supreme Court is set to hear oral arguments in this appeal on July 13.

Figure 2: Who are the 127,000 uninsured adults in the coverage gap in Missouri?

If the ACA Medicaid expansion does not proceed, the nearly 127,000 uninsured nonelderly adults who currently fall into the coverage gap would remain ineligible for coverage (Figure 2). These adults would be eligible if the state expanded but currently have incomes above Missouri’s current Medicaid levels (0% of the federal poverty level (FPL) for childless adults and 21% for parents) but below the 100% FPL ($12,880 for an individual or $21,960 for a family of 3 in 2021) minimum eligibility for tax credits through the ACA marketplace. National estimates by KFF indicate that nearly 2.2 million adults are in the coverage gap across all non-expansion states (these estimates exclude Missouri as the state had previously been scheduled to implement expansion in July). As in other states, most people in the coverage gap in Missouri are adults without dependent children (75%). Though most people in the Missouri coverage gap are White (74%), the gap disproportionately includes people of color when compared to the population of Missouri as a whole (79% White, non-Hispanic). Most (63%) adults in the coverage gap have at least one full-time (41%) or part-time only (22%) worker in their family. Without Medicaid expansion, those in the coverage gap have limited options for affordable health coverage and are likely to face barriers to needed health services.

Figure 3: What would be the fiscal impact of Medicaid expansion in Missouri?

Not expanding Medicaid in Missouri would lead the state to forego more than $1 billion in additional federal funds available under the American Rescue Plan Act (ARPA) (Figure 3). Governor Parson’s proposed FY 2022 budget allocated $1.57 billion in total for the Medicaid expansion; the federal government would cover the vast majority of this cost as states receive a 90% federal matching rate (FMAP) for the expansion population. The Missouri Legislature estimated that state costs of expansion would be $156 million in FY 2022, but ultimately chose not to appropriate these funds. The state has recently seen increasing revenue and an unprecedented budget surplus. ARPA provides a temporary fiscal incentive for states to newly implement the ACA Medicaid expansion by providing a 5 percentage point increase in the state’s traditional FMAP for two years. This increase would more than offset Missouri’s increased costs of expansion: Missouri would receive an estimated $1.15 billion over FY 2022 to 2023 as a result of the ARPA financial incentive. However, the state would ultimately need to cover its 10% share of the cost of expansion over time.

A comprehensive literature review of Medicaid expansion studies identifies positive financial impacts of expansion for state budgets and economies, on top of improvements in coverage, access, and health outcomes for individuals. Excluding Missouri, the other 12 non-expansion states are foregoing an estimated $16.4 billion in additional federal funds available under the ARPA incentive (on top of the existing 90% expansion FMAP). Similar to Missouri, Oklahoma voters approved a Medicaid expansion initiated constitutional amendment in June 2020; unlike Missouri, however, expansion coverage in Oklahoma is scheduled to begin on July 1. Since ARPA was enacted prior to the implementation of the expansion, Oklahoma is eligible for the ARPA fiscal incentive. Enrollment in expansion coverage began June 1 in Oklahoma and neared 100,000 after just one week. While fiscal issues are part of the calculus for states not expanding Medicaid—i.e., the need to cover 10% of the cost over time—opposition to the ACA continues to be a factor as well.

News Release

Workers Are More Likely to Get a COVID-19 Vaccine When Their Employers Encourage It and Provide Paid Sick Leave, Though Most Workers Don’t Want Their Employers to Require It

3 in 4 Adults Live in Homes Where Either Everyone is Vaccinated or Everyone Remains Unvaccinated

Published: Jun 30, 2021

A Third of Parents with Kids Ages 12-17 Report Their Kids Are Now Vaccinated; Most Parents Oppose Mandatory Vaccinations for School Children

As more employers return to in-person work, the latest KFF COVID-19 Vaccine Monitor report shows that workers are more likely to have gotten a COVID-19 vaccine when their employer encourages it or provides paid sick leave to get the vaccine and recover from side effects.

About two-thirds of workers report that their employer is encouraging vaccinations, and half say that their employer is providing paid time off for workers to get the vaccine and recover from any side effects.

Those actions appear to have an effect: About three-quarters of workers whose employers encourage getting a vaccine (73%) or offer paid time off to do so (75%) say the have gotten at least one shot, significantly more than the shares whose employers don’t encourage vaccination (41%) or don’t offer paid time off (51%). The differences persist even after controlling for workers’ age, race and ethnicity, education, income, party identification and other demographic characteristics.

Relatively few workers say that their employer required them (9%) or offered a cash bonus or other incentive (12%) to get a vaccine.

While the public overall is split on whether employers should require workers to get vaccinated unless they have a medical excuse (51% favor, 46% oppose), most workers (61%) say they do not want their own employer to require vaccinations. Opposition is especially high among workers who are not yet vaccinated (92% oppose a mandate) and among those who identify as or lean Republican (85%).

“Getting more Americans vaccinated isn’t only up to the government. Even without requiring workers to get a vaccine, employers can play a role by offering paid time off to get vaccinated and encouraging their workers to do so,” KFF President and CEO Drew Altman said.

Overall, nearly two-thirds (65%) of adults report having gotten at least one dose of a COVID-19 vaccine, up only slightly since May (62%). An additional 3% say they want to get a vaccine as soon as they can, and one in ten (10%) say they want to “wait and see” how the vaccine works for others before getting it.

About a fifth of the public remains in the more resistant categories, saying they that would get a vaccine “only if required” for work, school or other activities (6%), or that they will “definitely not” get a vaccine (14%). These shares are essentially unchanged since January even as most other adults got vaccinated.

Most adults are in homes where everyone else shares their vaccination status. Half (50%) of adults say that they and everyone in their household have gotten at least one shot, while a quarter (25%) say that neither they nor anyone else in their household has gotten a shot.

Two-thirds (67%) of Democrats say they live in fully vaccinated households, while nearly four in ten Republicans (37%) live in completely unvaccinated homes.

With new COVID-19 cases at their lowest level since testing became widely available more than a year ago, about three-quarters (76%) of the public now says they are optimistic that the country is nearing the end of the pandemic.

This optimism ironically may be contributing to the slowdown in new vaccinations. Half (50%) of those who are unvaccinated say that cases are now so low that there is no need for more people to get a shot. In comparison, the vast majority (91%) of people who have gotten at least one dose say that more people still need to get vaccinated. These findings underscore the importance of vaccine communication that emphasizes that the pandemic is not over.

What Might Increase Vaccination Rates?

The Monitor also looks at other potential incentives or developments that could boost vaccine take-up rates among those currently unvaccinated, particularly among those in “wait and see” mode.

Similar to last month, the new report finds that three in ten (31%) unvaccinated adults – and roughly half (49%) of the “wait and see” group – say that they would be more likely to get a vaccine if the U.S. Food and Drug Administration (FDA) granted full approval for one of the available vaccines.

However, those views may be more of a proxy for general safety concerns, as just a third (32%) of adults overall are aware that the FDA has only authorized the existing vaccines for emergency use while the rest either believe the vaccines already have full approval (21%) or aren’t sure (45%). Among unvaccinated adults who are aware that the vaccines are available under emergency use authorization, 32% say they would be more likely to get a vaccine if it were fully approval by the FDA.

Other potential motivators for the unvaccinated include:

• Nearly a quarter (23%) say they would be more likely to get vaccinated if they were entered in a lottery with a chance to win $1 million. This includes even larger shares of unvaccinated young adults ages 28-29 (33%), Black adults (34%) and those with household incomes under $40,000 annually (31%).

• About one in six (17%) say they would be more likely to get vaccinated if a mobile clinic came to their neighborhood. The share is higher among Hispanic (33%) and Black (22%) adults than among White adults (10%).

• Among unvaccinated parents, 13% say they would be more likely to get vaccinated if they were provided free childcare to get the vaccine and while they recover from side effects.

Vaccination Rates Among Children Ages 12-17 Rise, though Many Parents Worry about Heart IssueLess than two months after the FDA authorized the emergency use of a COVID-19 vaccine for children as young as 12 years old, a third (34%) of parents with children ages 12-17 say their children have already received at least one dose of the vaccine, up from a quarter (24%) in May. An additional 8% say they will get their 12-17 year old children vaccinated right away.

Parents of younger children who are not yet eligible to get a COVID-19 vaccine remain more cautious. About a quarter (27%) say they would get their child vaccinated as soon as they are able, while a third (33%) want to “wait and see.” Others say they would get their younger children vaccinated only if required by their school (11%) or not at all (26%).

Large shares of the public (67%) and of parents (74%) say they have heard at least a little about the U.S. Centers for Disease Control and Prevention (CDC) investigation about 800 cases of rare heart problems and inflammation that has occurred in some teenagers and young adults after they were vaccinated.

About half of parents (50%) say they are at least somewhat concerned about the risk. These parents tend to be more cautious about getting their children vaccinated than parents who haven’t heard about the potential heart issue or aren’t concerned about it.

Most parents (61%) say they do not think K-12 schools should require students to get vaccinated for COVID-19. This reflects a significant partisan divide, with most parents (58%) who identity as Democrats or lean that way saying schools should mandate vaccinations, while nearly eight in ten (79%) of those who identify as Republicans or lean that way saying they shouldn’t.

When it comes to colleges and universities, similar majorities of the public (58%) and of college students (58%) favor a requirement that all students get vaccinated unless they have a medical excuse. These views also diverge along partisan lines, with Democrats more than twice as likely to support a vaccination mandate at colleges and universities than Republicans are (82% vs. 33%).

Poll Finding

KFF COVID-19 Vaccine Monitor: June 2021

Published: Jun 30, 2021

Findings

The KFF COVID-19 Vaccine Monitor is an ongoing research project tracking the public’s attitudes and experiences with COVID-19 vaccinations. Using a combination of surveys and qualitative research, this project tracks the dynamic nature of public opinion as vaccine development and distribution unfold, including vaccine confidence and acceptance, information needs, trusted messengers and messages, as well as the public’s experiences with vaccination.

Key Findings

  • Reflecting other data indicating a slowdown in U.S. COVID-19 vaccination rates, the latest KFF COVID-19 Vaccine Monitor finds that nearly two-thirds of adults (65%) have received at least one vaccine dose, with only a small share (3%) saying they intend to get the vaccine as soon as they can. While vaccine intentions vary by party, race, ethnicity, age, and other demographics, at least half across most demographic groups now report being vaccinated, with the exception of those who lack health insurance, 48% of whom say they have received at least one dose of a COVID-19 vaccine.
  • In a new measure, we find that most adults live in homogenous households when it comes to COVID-19 vaccination status, with three-quarters (77%) of vaccinated adults saying everyone in their household is vaccinated and a similar share (75%) of unvaccinated adults saying no one they live with is vaccinated. Overall, half of adults report living in vaccinated households and one in four live in fully unvaccinated households. The remainder, about one in five adults, live in households with both vaccinated and unvaccinated household members including some households with children under the age of 12 who are not currently eligible to receive a vaccine. Notably, two-thirds of Democrats report living in all-vaccinated households while four in ten Republicans (39%) report living in all-unvaccinated homes.
  • With COVID-19 case rates at record lows and much of the country re-opening, most adults (76%) are optimistic that the U.S. is nearing the end of the pandemic. However, this optimism has the potential to hamper further vaccination efforts, with half of unvaccinated adults saying that the number of cases is now so low there is no need for more people to get the vaccine.
  • Consistent with last month’s results, three in ten unvaccinated adults, rising to about half of those in the “wait and see” group, say they would be more likely to get vaccinated if one of the vaccines currently authorized for emergency use were to receive full approval from the FDA. However, this finding likely suggests that FDA approval is a proxy for general safety concerns, as two-thirds of adults (including a large majority of unvaccinated adults) either believe the vaccines currently available in the U.S. already have full approval from the FDA or are unsure whether they have full approval or are authorized for emergency use. In terms of other incentives and interventions, a million dollar lottery could motivate about a quarter of the unvaccinated to get a shot, while mobile vaccine clinics motivate about one in six overall, but notably higher shares of Black and Hispanic adults, suggesting such outreach could help further reduce racial and ethnic disparities in vaccination rates.
  • Two-thirds of employed adults say their employer has encouraged workers to get vaccinated and half say their employer provided them paid time off to get the vaccine or recover from side effects. Notably, workers who say their employer did either one of these things are more likely to report being vaccinated, even after controlling for other demographics, suggesting that more employers encouraging vaccination and offering paid time off could lead to higher vaccination rates among U.S. workers.
  • While half the public overall say employers should require their workers to get vaccinated, most workers do not want their own employer to require vaccination, including the vast majority of unvaccinated workers (92%) as well as four in ten workers who are already vaccinated (42%).  About four in ten adults say employers should provide cash bonuses or other incentives to workers who get vaccinated, but just 12% of workers say their own employer has offered such an incentive.
  • Reported vaccination rates continue to increase among children ages 12-17, with one-third of parents of children in this age range saying their child has received at least one vaccine dose, up from 24% in May. However, many parents are still waiting and one-quarter say they will “definitely not” vaccinate their child. Similar to employer requirements, about half the public overall supports K-12 schools requiring COVID-19 vaccination, but most parents are opposed, with divisions along partisan lines. A somewhat larger share of the public (58%) says colleges and universities should require students to be vaccinated, including 58% of those who say they are currently undergraduate or graduate students.

Reflecting other data indicating a slowdown in U.S. COVID-19 vaccination rates, the latest KFF COVID-19 Vaccine Monitor reports that about two-thirds of adults (65%) now say they have received at least one dose of a vaccine, up only slightly from May (62%). An additional 3% of adults say they intend to get the vaccine as soon as possible. One in ten adults say they want to “wait and see” before getting vaccinated, trending downward over time but statistically similar to the share that said the same last month (12%). The shares of adults who are more reluctant to get the COVID-19 have remained relatively unchanged since January, with about one in five saying they either will get a vaccine “only if required” for work or other activities (6%) or will “definitely not” get vaccinated (14%).

Among those who say they want to “wait and see” before getting vaccinated, a critical group to efforts to increase the adults vaccination rate, about a quarter (3% of all adults) say they plan to get vaccinated within the next three months. Notably, four in ten adults (37%) in the “wait and see” group say they are likely to wait more than a year before getting vaccinated.

As Rate Of Increase In COVID-19 Vaccine Uptake Slows, Two-Thirds Of Adults Report Receiving At Least One Dose

Demographic patterns in vaccine uptake and intentions are similar to those measured in previous surveys, with large majorities of older adults, those with serious health conditions, college graduates, and Democrats saying they have gotten at least one dose of the COVID-19 vaccine. Black and Hispanic adults along with younger adults remain somewhat more likely than their counterparts to say they will “wait and see” before getting vaccinated, while Republicans, rural residents, and White Evangelical Christians continue to be disproportionately more likely to say they will definitely not get vaccinated.

While younger adults remain less likely to report being vaccinated, the largest increases in self-reported vaccination between May and June were among those ages 18-29 (from 48% to 55%) and those ages 30-49 (from 51% to 59%).

There remains a large gap in vaccine uptake across education, with about eight in ten college graduates (79%) saying they have gotten at least one dose of the COVID-19 vaccine, compared to about six in ten adults without a degree who say the same (59%). There is also a large gap among adults under age 65 by insurance status, with 62% of insured adults reporting receiving at least one dose compared to about half (48%) of uninsured adults. Notably, however, with the exception of individuals without health insurance, at least half of adults across all demographic subgroups say they have received at least one dose of a vaccine.

Across Most Subgroups, At Least Half Report Receiving A COVID-19 Vaccine

A gender gap in vaccine uptake has emerged over the past several months, and women are now 9 percentage points more likely to report being vaccinated than men (70% vs. 61%), and a larger share of men than women say they will “definitely not” get the vaccine (17% vs. 11%). This difference appears to largely reflect differences in partisan identification between men and women, with 43% of men identifying as Republicans or Republican-leaning independents compared to 27% of women. In fact, self-reported vaccination rates are similar by partisanship across genders with half of Republicans and Republican-leaning men and women reporting receiving at least one dose  (50% of men and 52% of women) compared to eight in ten Democratic men and women (78% of men and 82% of women).

Vaccination Status of Households

This month’s Monitor finds that most U.S. households are homogeneous when it comes to their COVID-19 vaccination status. Half of adults report living in a vaccinated household (those in which every household member has received at least one dose of a COVID-19 vaccine) while one in four live in fully unvaccinated households (those in which no household member has been vaccinated) and about one in five live in a household with both vaccinated and unvaccinated individuals. Across partisans, two-thirds of Democrats say they live in a fully vaccinated household while nearly four in ten Republicans (37%) say they live in a fully unvaccinated household.

Three in four vaccinated adults (77%) say they live in fully vaccinated households while a similar share of unvaccinated adults (75%) say everyone in their household is unvaccinated. Among vaccinated adults living in a mixed-status household, one-third (34%) say all the unvaccinated members of their household are under age 12 and therefore ineligible to receive a COVID-19 vaccine, while the majority (65%) say at least one of their unvaccinated household members is age 12 or over and therefore eligible to get vaccinated.

Half Of Adults Live In Fully Vaccinated Households While One Quarter Live In A Fully Unvaccinated Household

How Optimism About The Pandemic’s End May Affect Vaccination Efforts

With COVID-19 cases at their lowest point since testing became widely available, and as the nation continues to open up with increased travel, large public events returning, and mask mandates being rescinded, about three-quarters of the public (76%) say they are optimistic that the U.S. is nearing the end of the COVID-19 pandemic. Vaccinated adults are somewhat more likely than those who are unvaccinated to express optimism, though large shares of both groups are optimistic (78% vs. 70%).

Public optimism about the end of the pandemic has the potential to hinder further vaccination efforts if low case rates decrease people’s sense of risk and therefore decrease their sense of urgency about getting vaccinated. The latest Monitor finds some evidence that this may be happening to a certain extent among unvaccinated adults. Overall, 73% of the public feels that “more people need to get the vaccine to help stop the spread of COVID-19,” while 22% say the number of cases “is so low that there is no need for more people to get the vaccine.” While the vast majority (91%) of vaccinated adults say that more people need to get vaccinated, half of unvaccinated adults say cases are so low that additional vaccinations are not necessary. This includes 43% in the potentially convertible “wait and see” group as well as two-thirds of those who say they will “definitely not” get the vaccine.

Half Of Unvaccinated Adults Say Cases Are So Low That There Is No Need For More People To Get Vaccinated

Concerns about the efficacy of the COVID-19 vaccines against new coronavirus variants could also deter some from getting vaccinated. Nearly half of unvaccinated adults, including six in ten of those in the “wait and see” group say they are worried that the currently available COVID-19 vaccines might not be effective against new strains of coronavirus.

Six In Ten Adults Who Want To &quot;Wait And See&quot; Before Getting Vaccinated Are Worried The Vaccine Won't Be Effective Against New Coronavirus Strains

Reasons Why Some Adults Remain Unvaccinated

Unvaccinated adults cite a variety of reasons why they have not gotten a COVID-19 vaccine, with half citing worries about side effects and the newness of the vaccine as major reasons (53% each). Other major reasons include just not wanting to get the vaccine (43%), not trusting the government (38%), thinking they do not need the vaccine (38%), not believing the COVID-19 vaccines are safe (37%), and not trusting vaccines in general (26%). Fewer cite as major reasons that they have a medical reason for not getting vaccinated (14%), they are too busy or have not had the time to get it (12%), they don’t like getting shots (12%), they are worried about missing work (7%), they would have difficulty traveling to a vaccination site (6%), they are worried about having to pay (5%), or they are not sure how or where to get the vaccine (5%).

When unvaccinated adults are asked to choose the main reason they have not yet gotten the COVID-19 vaccine, one in five cite the newness of the vaccine, followed by 11% each who say the main reason is that they are worried about side effects, they don’t trust the government, they don’t think they need the vaccine, and they just don’t want to get the vaccine.

Newness Of COVID-19 Vaccines And Worries About Side Effects Are Top Reasons Why Some Remain Unvaccinated

Reasons for not getting vaccinated differ between those in the “wait and see” group and those who say they will “definitely not” get vaccinated, as well as between unvaccinated adults with different partisan identities and those from different racial and ethnic backgrounds. While the newness of the vaccine and worries about side effects are prominent across groups, the vaccine’s newness is cited as a major reason by a larger share of those in the “wait and see” group compared to the “definitely not” group (67% vs. 52%). By contrast, those in the “definitely not” group are much more likely than those in the “wait and see” group to say they just don’t want to get the vaccine (63% vs. 25%), they don’t trust the government (55% vs. 29%), they don’t think they need the vaccine (54% vs. 21%), and that they don’t believe the vaccines are safe (50% vs. 31%).

When asked to choose the main reason they haven’t gotten vaccinated, the top two answers among the “wait and see” group are that the vaccine is too new (38%) and that they are worried about side effects (18%); among the “definitely not” group, the top reasons are they don’t trust the government (19%) and they just don’t want to get vaccinated (12%).

Consistent with previous research, unvaccinated Hispanic and Black adults are more likely than White adults to cite worries about missing work and having to pay for the vaccine as major reasons for not being vaccinated. In addition, unvaccinated Hispanic adults are more likely than unvaccinated White adults to say they are too busy, would have difficulty traveling to a vaccination site, or are not sure how or where to get the vaccine.

By partisanship, larger shares of unvaccinated Republicans than Democrats say they don’t want or need the vaccine, they don’t trust the government, or don’t believe the vaccines are safe. Larger shares of unvaccinated Democrats than Republicans say they are too busy, don’t like getting shots, or are worried about missing work.

Table 1: Major Reasons Why Unvaccinated Adults Have Not Gotten A COVID-19 Vaccine
Percent who say each is a MAJOR reason why they haven’t gotten vaccinated:Total unvaccinatedCOVID-19 Vaccination intentionRace/EthnicityParty ID
Wait and seeDefinitely notBlackHispanicWhiteDem.Ind.Rep.
The vaccine is too new53%67%52%55%54%54%63%50%51%
Worried about side effects535761556051575451
Just don't want to get the vaccine432563303448363455
Don't trust the government382955313440253547
Don't think they need the COVID-19 vaccine382154274238252847
Do not believe the COVID-19 vaccines are safe373150293840303446
Don't trust vaccines in general261938272126272726
Have a medical reason why they can't get the vaccine at this time1414177181591714
Too busy or have not had time to get it121361722917105
Don't like getting shots12121017141022124
Worried about missing work77391831183
Difficult to travel to a vaccination site6935134774
Not sure how or where to get the vaccine5726132651
Worried they will have to pay to get the vaccine57110122661

What Might Increase Vaccination Rates?

The May KFF COVID-19 Vaccine Monitor found that if the FDA were to give full approval to one of the COVID-19 vaccines, it could move some unvaccinated adults to get the vaccine. Findings were similar this month with 31% of unvaccinated adults saying they would be more likely to get a vaccine if one of the vaccines currently authorized for emergency use received full approval by the FDA, rising to nearly half of those in the “wait and see” group.

However, this reported increased likelihood does not necessarily reflect a nuanced understanding of the FDA approval process among unvaccinated adults and may be a proxy for more general concerns about safety. Two-thirds of the public either are unsure if the FDA has given full approval of the COVID-19 vaccines (45%) or think it has done so (21%), while just a third (32%) know that the vaccines have only been authorized for emergency use. Among unvaccinated adults, a majority (57%) say they are unsure whether the FDA had granted full approval or only emergency use authorization to the COVID-19 vaccines currently available in the U.S.

Among unvaccinated adults who are aware that the vaccines are available under emergency use authorization, a similar share as among all unvaccinated adults – 32% - say they would be more likely to get vaccinated if one of the vaccines were granted full approval by the FDA.

Most Adults Are Unaware That COVID-19 Vaccines Are Currently Available Under FDA Emergency Use Authorization

Over the past several months, we have been using the Vaccine Monitor surveys to test a number of potential incentives that may resonate with those who remain unvaccinated. Along with the 31% of unvaccinated adults who say they would be more likely to get the vaccine if the FDA granted full approval, the incentive tested in this month’s Monitor that appears to have the most resonance is a lottery with the chance to win one million dollars. About one in four (23%) of those who have not been vaccinated, including 31% of those who say they want to “wait and see,” say they would be more likely to get vaccinated if they were entered into a lottery with a chance to win one million dollars. Among the unvaccinated, about a third of adults ages 18 to 29 (33%), Black adults (34%), and those with a household income under $40,000 (31%) say being entered in a lottery would make them more likely to get the vaccine.

Incentives targeting vaccine access may also help increase vaccination rates and reduce racial and ethnic disparities in who is getting vaccinated. Seventeen percent of unvaccinated adults overall say they would be more likely to get vaccinated if a mobile vaccine clinic came to their neighborhood, a share that rises to nearly one-fourth of unvaccinated Black adults (22%) and one-third of Hispanic adults. In addition, 13% of unvaccinated parents say they would be more likely to get a vaccine if they were provided with free childcare while they get the vaccine and recover from side effects.

FDA Approval, Vaccine Lotteries, Mobile Clinics, And Free Childcare May Convince Some To Get Vaccinated

The Role of Employers in COVID-19 Vaccination

Workplace Vaccination Status And Feelings Of Safety

With businesses reopening across the country and many workplaces returning to in-person work, employers have a large role to play in providing worker with information about COVID-19 vaccines, encouraging them to get vaccinated, and making sure they can get vaccinated without losing pay. Among adults who are employed at least part-time, most (61%) now say they are working from a location outside their home, while one in five (19%) say they work solely from their home and another one in five (21%) say they work partially at home and partially at another location.

Although they may be at higher risk for exposure to coronavirus, those who work solely (54%) or partially (66%) outside their home are less likely to report receiving a COVID-19 vaccine compared to those who work solely from home (81%). Compared to those working from home, a larger share of those working solely outside their home say they will “wait and see” before getting vaccinated (15% vs. 4%) or that they will “definitely not” get the vaccine (18% vs. 8%). These differences are likely driven by other demographic factors, as those who work at home are more likely to be college-educated and to identify as Democrats compared to those who work outside their homes.

Those Working From Home Have Higher Self-Reported Vaccination Rates Than Those Working Outside The Home

Just as many households are homogeneous in their vaccination status, the latest Vaccine Monitor finds that many workplaces are as well. Among those who work at least partially outside their home, one-third (34%) say that all or most of their coworkers have been vaccinated for COVID-19 and another quarter (27%) say about half of their coworkers have been vaccinated. Notably, about half (53%) of those who have been vaccinated themselves say that all or most of their coworkers have been vaccinated while a similar share (49%) of unvaccinated workers say just a few or none of their coworkers have received a vaccine. There is also a large education divide among those working outside the home, with about half (52%) of workers who are college graduates saying all or most of their coworkers have been vaccinated compared to one-quarter of workers without a college degree. Notably, about one in ten of those working outside their home overall say they don’t know what share of their coworkers have received a COVID-19 vaccine.

Vaccinated Workers, College Graduates More Likely To Report That Most Of Their Coworkers Are Vaccinated

Despite mixed workplace vaccination status, the vast majority of workers say they feel at least somewhat safe when it comes to their risk of exposure to coronavirus when working outside their home, including 58% who say they feel “very” safe and 34% who feel “somewhat” safe. Black and Hispanic workers are less likely to report feeling “very” safe working outside their home compared to White workers (40%, 45%, and 66%, respectively), as are lower-income workers compared to those with higher incomes (47% of those with household incomes less than $40,000 vs. 66% of those with incomes of $90,000 or more).

Most Workers Feel Safe When Working Outside Their Home, But Fewer Black, Hispanic, And Lower-Income Workers Feel &quot;Very Safe&quot;

Among those who work outside their homes, a larger share of those who have not received a COVID-19 vaccine says they feel “very safe” compared to those who have received a vaccine (72% vs. 46%). This likely reflects the fact that those who have chosen not to get a COVID-19 vaccine are less likely to view the virus as a threat to their personal health. Among those who have been vaccinated, feelings of safety from exposure to the virus do not appear to be correlated with beliefs about coworkers’ vaccination status; about half of vaccinated workers say they feel “very safe” among those who say all or most of their coworkers have been vaccinated and among those who say half or fewer of their coworkers have gotten a vaccine.

Vaccinated Workers Less Likely To Feel &quot;Very Safe&quot; At Work Compared To Unvaccinated Workers

The Role Of Employers In Encouraging Vaccinations

Among the different roles employers might play, we find the most common are providing information and encouraging vaccination. Seven in ten of those who work for an employer say their employer has provided them with information about how to get a COVID-19 vaccine, and two-thirds (65%) say their employer has encouraged employees to get vaccinated. A larger share of workers with college degrees compared to those without college degrees say their employer has provided information (77% vs. 66%) or encouraged employees to get vaccinated (78% vs. 57%). Notably, 72% say they trust their employer a great deal or a fair amount to provide reliable information about the vaccines.

Half of workers overall say their say their employer provides them with paid time off to get a COVID-19 vaccine and recover from any side effects, though this share is lower among Black workers (38%), those without college degrees (41%), and those with household incomes less than $40,000 annually (41%). Among workers who don’t have health insurance, just one-third (33%) say their employer provides paid time off for vaccine administration and side effects.

About one in ten workers say their employer offered a cash bonus or other incentive to employees who get vaccinated (12%) or required them to get a COVID-19 vaccine (9%). The share saying their employer offered cash or another incentive rises to 22% among Black employees and 16% among those in households earning between $40,000 and $89,999 annually. One in six workers with household incomes under $40,000 (17%) say their worker required them to get vaccinated compared to smaller shares of those in middle- and higher-income households (4% and 7%, respectively).

Table 2: Employer Provided Vaccination Incentives By Race, Education, Income And Insurance Status
Percent of employed adults whose employer has done each of the following:Total employedRace/EthnicityEducationHousehold IncomeInsurance status
BlackHispanicWhiteLess than collegeCollege graduateLess than $40K$40K-$89.9K$90K+Insured under age 65Uninsured under age 65
Provided them with information about how to get a COVID-19 vaccine70%67%67%70%66%77%69%71%72%70%57%
Encouraged employees to get vaccinated6568686457786066696558
Provided them with paid time off to get the vaccine or to recover from any side effects5038514941644147635133
Offered a cash bonus or another type of incentive to employees who get vaccinated122211111311121671115
Required them to get a COVID-19 vaccine91397811174799

Workers who say their employer provided them with paid time off to get a COVID-19 vaccine and recover from side effects and those who say their employer encouraged vaccination are more likely to report receiving a COVID-19 vaccine compared to those whose employers have not taken these actions. Three-quarters of those who got paid time off say they’ve received at least one dose of the vaccine compared to about half (51%) of those who did not have this benefit. Similarly, 73% of those who say their employer encouraged vaccination report getting at least one dose compared to four in ten (41%) of those whose employer did not.

At least part of this difference may be due to differences in other demographic characteristics of those whose employers engaged in these activities compared to those who did not. However, using a statistical technique called multiple logistic regression, we find that employees who are encouraged by their employers to get vaccinated, or who are provided paid time off are more likely to get vaccinated, even after controlling for age, race, ethnicity, education, income, party identification, and other demographic characteristics that may impact vaccination uptake. This suggests that more employers encouraging vaccination and offering paid time off could lead to higher vaccination rates among employed adults in the U.S.

Workers Whose Employers Provided Paid Time Off Or Encouraged Vaccination Or  Are More Likely To Report Being Vaccinated

Views on Employer Requirements and Incentives

The public overall is divided in their views of employer requirements for COVID-19 vaccination, with about half (51%) saying employers should require employees to get vaccinated unless they have a medical exemption and a similar share (46%) saying they should not. Somewhat fewer support employers offering financial incentives, with four in ten (39%) saying employers should offer cash bonuses and other incentives to employees who get vaccinated and a majority (57%) saying employers should not do this.

On each of these questions, views diverge largely along partisan lines and by vaccination status. Three-quarters of Democrats (73%) support employers requiring COVID-19 vaccination compared to about half of independents (47%) and three in ten Republicans. Similarly, Democrats (52%) and independents (42%) are more likely than Republicans (21%) to say employers should offer incentives for vaccinated employees. Vaccinated adults are also more likely than unvaccinated adults to support employer requirements (68% vs. 19%) and financial incentives (45% vs. 29%).

Public Split On Employer Vaccination Requirements, Fewer Support Employer Incentives

Although about half the public overall supports employers requiring workers to get vaccinated, most of those who work for an employer say they do not want their own employer to require employees to get vaccinated (61%). About three in ten (28%) say they want their employer to require vaccination and another 9% say their employer already requires it. As among the public, views among workers diverge by partisanship and vaccination status. The vast majority of Republican workers (85%) and six in ten of those who identify as independents (62%) say they do not want their employer to require vaccination, while over half of Democrats say they want their employer to require it (46%) or that they already do (16%).

Not surprisingly, nine in ten (92%) unvaccinated workers don’t want their employer to require them and other employees to get a COVID-19 vaccine. When unvaccinated workers are asked what they would do if their employer required them to get vaccinated to continue working, four in ten (42%) say they would get the vaccine and half say they would leave their job.

Vaccinated workers are split on the question of employer requirements, with roughly equal shares saying they do (43%) and do not (42%) want their employer to require vaccination and 13% saying it is already required. Notably, vaccinated workers’ views on employer vaccination requirements are similar regardless of whether they report working in a mostly-vaccinated or a mostly-unvaccinated workplace.

Most Workers Do Not Want Their Employer To Require COVID-19 Vaccination, But Vaccinated Workers Are Split

Views On COVID-19 Vaccines For Children And School Requirements

Parents’ Intentions for Vaccinating Children

About a month and a half after the FDA authorized the Pfizer COVID-19 vaccine for use in children ages 12 and older, the latest Monitor finds about four in ten (42%) parents of children ages 12-17 say their child has already received at least one dose of the vaccine (34%) or that they will get them vaccinated right away (8%). About one in five parents of adolescents say they will “wait a while to see how it is working” before getting their child vaccinated (18%), while one in ten say they will get their child vaccinated only if their school requires it and an additional one in four say they will “definitely not” get their 12-17 year-old vaccinated.

Since May, the share of parents who say their 12-17 year old child has been vaccinated has risen by about ten percentage points while the share who say they will get their child vaccinated “right away” has fallen by a similar amount. From May to June, the shares of parents who say they want to “wait a while to see how it is working,” will only get their child vaccinated if their school requires it, or will “definitely not” get their child vaccinated has remained about the same.

When those who say they want to wait and see before getting their 12-17 year-old child vaccinated are asked how long they think they will wait, responses are split. Seven percent of all parents of children ages 12-17 say they will wait three months or less, 4% say they will wait between four months and one year, and 7% say they plan to wait longer than one year to vaccinate their child.

Four In Ten Parents Say Their Adolescent Has Already Received A COVID-19 Vaccine Or Will Do So Right Away, Similar To Last Month

Parents of younger children, for whom a COVID-19 vaccine is not yet authorized, remain more cautious in their approach to the vaccine. About one-quarter (27%) say they will get their child under age 12 vaccinated as soon as a vaccine is authorized for their age group, while one-third intend to wait a while to see how the vaccine is working. An additional 11% say they will vaccinate their young child only if school requires it and one-quarter (26%) say they will definitely not get them vaccinated. These shares are virtually unchanged from when this was first asked in May 2021.

One-Quarter Of Parents Of Children Under Age 12 Say They'll Get Their Child A COVID-19 Vaccine As Soon As It's Available

Among parents of younger children, intentions for vaccinating children vary by parents’ own vaccination status, their ethnicity, and party identification. Among parents of children under age 12 who have received a vaccine themselves, about half (48%) say they will get their younger child a vaccine as soon as one is authorized for their age group compared to just 4% of parents who have not received a vaccine. By contrast, nearly half (48%) of unvaccinated parents say they will “definitely not” get their child under age 12 vaccinated compared to 7% of parents who have received the vaccine themselves. A similar pattern emerges by partisanship, as nearly half (45%) of Democrats and Democratic-leaning parents of children under age 12 say they will get their child vaccinated “right away,” and the same proportion (46%) of Republicans and Republican-leaning independents say they will “definitely not” get their young child vaccinated. While similar shares of Hispanic and White parents say they will vaccinate their child under age 12 as soon as a vaccine is authorized, a larger share of Hispanic parents than White parents say they will “wait and see” (47% vs. 25%) while a smaller share say they will “definitely not” get the vaccine for their child (12% vs. 32%). (The sample size of Black parents of younger children is too small to report separately.)

Parents’ Intentions For Vaccinating Children Under Age 12 For COVID-19 Differ By Ethnicity, Partisanship, And Parent Vaccine Status

Recently, the CDC announced that it is investigating about 800 cases of rare heart problems and inflammation that have occurred in some teenagers and young adults after they received the Pfizer or Moderna COVID-19 vaccines. The CDC and many physician groups continue to strongly recommend vaccination for young people despite these rare cases.

Two-thirds of adults, rising to 74% of parents, say they have heard at least a little about these rare cases of heart problems in young people related to the vaccine. Among young adults ages 18-29, a somewhat smaller share (60%) say they’ve heard at least a little. Across age groups and parent status, few say they’ve heard “a lot” about these cases.

Two-Thirds Have Heard At Least A Little About Rare Heart Problems In Young People Vaccinated For COVID-19

About four in ten adults overall, rising to half of parents of children under age 18, say they have heard about rare cases of heart problems among young adults and teenagers who have been recently vaccinated for COVID-19 and that they are very or somewhat concerned about these cases.

Four In Ten Overall, Half Of Parents Are Concerned About Rare Cases Of Heart Problems In Young People Vaccinated For COVID-19

Parents of children ages 12-17 who have heard about and are concerned about heart problems linked to the COVID-19 vaccine in young people are notably more cautious about getting their children vaccinated compared to parents who say they are not concerned or have not heard about these cases. One-quarter (24%) of parents who express concern about these events say their child is already vaccinated compared to 45% of parents who haven’t heard or do not express concern.

Parents Of Children Ages 12-17 Who Are Concerned About Potential Heart Problems Are Less Likely To Say They Will Vaccinate Their Child For COVID-19

Views on Schools Requiring COVID-19 Vaccinations

The public overall is somewhat divided on whether schools should require students to get vaccinated for COVID-19. About half the public (52%) say K-12 schools should require students to get vaccinated unless they have a medical exemption while a similar share (45%) say they should not. Notably, parents of children under age 18 are less likely to say K-12 schools should require vaccination compared to adults who do not have minor children (37% vs. 57%). Among parents of children ages 12-17, for whom vaccines are currently authorized, 38% say that K-12 schools should require students to be vaccinated.

Overall public support is somewhat higher for colleges and universities requiring students to be vaccinated; 58% say they should, including 58% of those who are current undergraduate or graduate students at a college or university.

As is the case with employers requiring workers to be vaccinated, views on school requirements diverge largely along partisan lines and by vaccination status. Large majorities of Democrats support vaccination requirements by K-12 schools and universities compared to about half of independents and about a third of Republicans. At least seven in ten vaccinated adults support each type of requirement, compared to about one in five of those who have not been vaccinated.

More Than Half Say Colleges, Universities And K-12 Schools Should Require Students To Be Vaccinated; Fewer Parents Support K-12 Vaccination Requirements

Overall, six in ten (61%) parents of children under 18 say that K-12 schools should not require students to get vaccinated for COVID-19. However, similar to the partisan split among the general public on this question, parents are split on partisan lines. Nearly six in ten (58%) parents who identify as Democrats or lean that way say K-12 schools should require students to be vaccinated, while about eight in ten (79%) Republican-leaning parents say they should not require this.

Parents' Views Of K-12 School Vaccination Requirements Diverge Along Partisan Lines

Who Do People Trust For Reliable Information On COVID-19 Vaccines?

When asked who they trust to provide reliable information about the COVID-19 vaccines, personal doctors, including pediatricians, top the list, with 83% of adults saying they trust their own doctor a great deal or a fair amount and 85% of parents saying the same about their child’s pediatrician. Employers and health insurance companies also garner a high degree of trust, with 72% of workers saying they trust their employer and 73% of those with health insurance saying they trust their insurer to provide reliable vaccine information. About seven in ten each say they trust the CDC (71%), the FDA (69%), and their local public health department (69%). Somewhat fewer, but still more than half, trust President Joe Biden (58%), Dr. Anthony Fauci (57%), and their state government officials (56%). Levels of trust in most government sources of information has remained steady since this question was last asked in December 2020, but trust in Dr. Fauci has fallen somewhat, from 68% to 57%.

Personal Doctors And Pediatricians Are The Most Trusted Source For Reliable COVID-19 Vaccine Information

Among unvaccinated adults, majorities trust their own doctor, their child’s pediatrician, their health insurance company, and their employer for reliable information about COVID-19 vaccines, while trust in other sources is somewhat lower than among vaccinated adults. About half of unvaccinated adults say they trust the CDC, FDA, and their local health department, while about four in ten trust their state government officials and fewer trust President Biden (32%) or Dr. Fauci (27%). Trust in government sources of information is especially low among those who say they will “definitely not” get the vaccine.

Table 3: Trust In Sources Of COVID-19 Vaccine Information By Vaccination Status And Intention
Percent who say they have a great deal or fair amount of trust in each of the following to provide reliable information about the COVID-19 vaccines:COVID-19 vaccination statusCOVID-19 vaccination intention
Total vaccinatedTotal unvaccinatedWait and seeDefinitely not
Their child’s pediatrician*95%73%--
Their own doctor8969  78%  60%
Their health insurance company**79607545
Their employer***78616064
The U.S. Centers for Disease Control and Prevention, or CDC82486228
The U.S. Food and Drug Administration, or FDA79516037
Their local public health department80495730
President Joe Biden72323615
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases7427348
Their state government officials64414627
NOTE: *Item asked only of those who are parents/guardians of children under 18 in household. Sample size too small for some subgroup analysis. **Item asked only of those who are insured. ***Item asked only of those who are employed and not self-employed.
Table 4: Trust In Sources Of COVID-19 Vaccine Information By Party ID
Percent who say they have a great deal or fair amount of trust in each of the following to provide reliable information about the COVID-19 vaccines:Party identification
DemocratIndependentRepublican
Their child’s pediatrician*88%85%-
Their own doctor888382%
Their health insurance company**827163
Their employer***836371
The U.S. Centers for Disease Control and Prevention, or CDC916948
The U.S. Food and Drug Administration, or FDA836856
Their local public health department866952
President Joe Biden915522
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases875530
Their state government officials715445
NOTE: *Item asked only of those who are parents/guardians of children under 18 in household. Sample size too small for some subgroup analysis. **Item asked only of those who are insured. ***Item asked only of those who are employed and not self-employed.

Methodology

This KFF COVID-19 Vaccine Monitor was designed and analyzed by public opinion researchers at the Kaiser Family Foundation (KFF). The survey was conducted June 8-21, 2021, among a nationally representative random digit dial telephone sample of 1,888 adults ages 18 and older (including interviews from 512 Hispanic adults and 497 non-Hispanic Black adults), living in the United States, including Alaska and Hawaii (note: persons without a telephone could not be included in the random selection process). Phone numbers used for this study were randomly generated from cell phone and landline sampling frames, with an overlapping frame design, and disproportionate stratification aimed at reaching Hispanic and non-Hispanic Black respondents as well as those living in areas with high rates of COVID-19 vaccine hesitancy. Stratification was based on incidence of the race/ethnicity subgroups and vaccine hesitancy within each frame. High hesitancy was defined as living in the top 25% of counties as far as the share of the population not intending to get vaccinated based on the U.S. Census Bureau’s Household Pulse Survey.  The sample also included 39 respondents reached by calling back respondents that had previously completed an interview on the KFF Tracking poll at least nine months ago. Another 309 interviews were completed with respondents who had previously completed an interview on the SSRS Omnibus poll (and other RDD polls) and identified as Hispanic (n = 142; including 78 in Spanish) or non-Hispanic Black (n=167). Computer-assisted telephone interviews conducted by landline (225) and cell phone (1,663, including 1,228 who had no landline telephone) were carried out in English and Spanish by SSRS of Glen Mills, PA. To efficiently obtain a sample of lower-income and non-White respondents, the sample also included an oversample of prepaid (pay-as-you-go) telephone numbers (25% of the cell phone sample consisted of prepaid numbers) Both the random digit dial landline and cell phone samples were provided by Marketing Systems Group (MSG). For the landline sample, respondents were selected by asking for the youngest adult male or female currently at home based on a random rotation. If no one of that gender was available, interviewers asked to speak with the youngest adult of the opposite gender. For the cell phone sample, interviews were conducted with the adult who answered the phone. KFF paid for all costs associated with the survey.

The combined landline and cell phone sample was weighted to balance the sample demographics to match estimates for the national population using data from the Census Bureau’s 2019 U.S. American Community Survey (ACS), on sex, age, education, race, Hispanic origin, and region, within race-groups, along with data from the 2010 Census on population density. The sample was also weighted to match current patterns of telephone use using data from the January- June 2020 National Health Interview Survey. The weight takes into account the fact that respondents with both a landline and cell phone have a higher probability of selection in the combined sample and also adjusts for the household size for the landline sample, and design modifications, namely the oversampling of prepaid cell phone numbers and areas with high incidence of Black or Hispanic residents or high levels of vaccine hesitancy, as well as the likelihood of non-response for the re-contacted sample. An additional weighting adjustment was made to account for survey break-off by COVID-19 vaccination status within each race/ethnicity group. All statistical tests of significance account for the effect of weighting.

The margin of sampling error including the design effect for the full sample is plus or minus 3 percentage points. Numbers of respondents and margins of sampling error for key subgroups are shown in the table below. For results based on other subgroups, the margin of sampling error may be higher. Sample sizes and margins of sampling error for other subgroups are available by request. Note that sampling error is only one of many potential sources of error in this or any other public opinion poll. Kaiser Family Foundation public opinion and survey research is a charter member of the Transparency Initiative of the American Association for Public Opinion Research.

This work was supported in part by grants from the Chan Zuckerberg Initiative DAF (an advised fund of Silicon Valley Community Foundation), the Ford Foundation, and the Molina Family Foundation. We value our funders. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

GroupN (unweighted)M.O.S.E.
Total1,888± 3 percentage points
COVID-19 Vaccination Status
Have gotten at least one dose of the COVID-19 vaccine1,285± 4 percentage points
Have not gotten the COVID-19 vaccine572± 6 percentage points
Race/Ethnicity
White, non-Hispanic754± 4 percentage points
Black, non-Hispanic497± 6 percentage points
Hispanic512± 5 percentage points
Party Identification
Democrats698± 6 percentage points
Republicans364± 7 percentage points
Independents497± 6 percentage points
Parents
Parents of children under 18 in household453± 6 percentage points
Parents of children ages 12-17239± 9 percentage points
Parents of children under 12 years old314± 8 percentage points
News Release

Poll: Few are Aware of Hospital Price Transparency Requirements

Published: Jun 28, 2021

Few Americans realize that starting this year hospitals are required to post prices of common health services on their websites in a format patients can access and use, data from the KFF Health Tracking poll shows.

Federal regulations that took effect January 1 require this price transparency for hospitals to allow patients to compare prices across hospitals and “shop” for lower-price care. The new survey data finds that 9% of adults nationwide are aware that hospitals must disclose this information online.

In addition, relatively few (14%) adults say they or someone in their family had gone online to research the price of treatment at a hospital over the past six months. This in part reflects that many families might not have a need for nonemergency hospital care at a given time.

The data note is available on the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S. health system.

Designed and analyzed by public opinion researchers at KFF, the KFF Health Tracking Poll was conducted from May 18-25 among a nationally representative random digit dial telephone sample of 1,526 adults. Interviews were conducted in English and Spanish by landline (248) and cell phone (1,278). The margin of sampling error is plus or minus 3 percentage points for the full sample. For results based on subgroups, the margin of sampling error may be higher.

Few Adults Are Aware of Hospital Price Transparency Requirements

Authors: Nisha Kurani, Audrey Kearney, Ashley Kirzinger, and Cynthia Cox
Published: Jun 28, 2021

A data note based on KFF polling data shows that few Americans realize that starting this year hospitals are required to post prices of common health services on their websites in a format patients can access and use.

Federal regulations that took effect January 1 require this price transparency for hospitals to allow patients to compare prices across hospitals and “shop” for lower-price care. The new survey data finds that 9% of adults nationwide are aware that hospitals must disclose this information online.

The data note is available on the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S. health system.

News Release

Black Medicare Beneficiaries Are More Likely Than White Beneficiaries to Have Cost-Related Problems with Their Health Care, Across both Traditional Medicare and in Medicare Advantage Plans

Rates of Cost-Related Problems are Higher Among Beneficiaries in Medicare Advantage Than in Traditional Medicare with Supplemental Coverage, But Highest Among Beneficiaries in Traditional Medicare without Supplemental Coverage

Published: Jun 25, 2021

Among people with Medicare, Black beneficiaries are more likely to have cost-related problems with their health care than White beneficiaries, finds a new KFF analysis, with the racial disparity persisting among beneficiaries in both traditional Medicare and Medicare Advantage plans.

While 17 percent of all Medicare beneficiaries, or about 1 in 6, reported health care cost-related problems in 2018, the rate among Black beneficiaries was double that among White beneficiaries (28% vs. 14%), according to the analysis of data from the 2018 Medicare Current Beneficiary Survey (MCBS).

Among Medicare Advantage enrollees, the rate of cost-related problems among Black beneficiaries was also higher than among White beneficiaries (32% vs. 16%), the analysis finds.

Among Black beneficiaries specifically, a larger share of those in Medicare Advantage reported cost-related problems than those in traditional Medicare (32% vs. 24%). The rate of cost-related problems was lower still among the subset of Black beneficiaries in traditional Medicare who had Medicaid or other sources of supplemental insurance (20%).

Cost-related problems were defined in the analysis as trouble getting care due to cost, a delay in care due to cost, or problems paying medical bills.

Across all Medicare beneficiaries, a somewhat smaller share of those in traditional Medicare than in Medicare Advantage reported cost-related problems (15% vs. 19%), with a lower rate among beneficiaries in traditional Medicare with supplemental coverage (12%). The analysis also shows that, overall and across racial and ethnic groups, the Medicare beneficiaries who are most likely to experience cost-related problems are those in traditional Medicare without supplemental coverage – 30 percent of whom reported cost-related problems in 2018.

Rates of cost-related problems were even higher among Black beneficiaries in fair or poor self-reported health, where half (50%) of those in Medicare Advantage experienced cost-related problems and one-third (34%) of those in traditional Medicare.

The analysis finds that enrollees in Medicare Advantage, who now account for more than 4 in 10 beneficiaries overall, do not generally receive greater protection against cost-related problems than beneficiaries in traditional Medicare with supplemental coverage, despite requirements for Medicare Advantage plans to have out-of-pocket limits. Differences in cost-related problems between Medicare Advantage and traditional Medicare with supplemental coverage are not fully explained by differences in the characteristics of beneficiaries, such as income and health status.

The new findings are noteworthy in that half of all Black beneficiaries are enrolled in Medicare Advantage (compared to just over one third of White beneficiaries).

However, the analysis does not estimate actual differences in average out-of-pocket spending among these groups, because it is not possible to derive comparable and accurate estimates of spending for Medicare Advantage enrollees using the Medicare Current Beneficiary Survey, as can be done for traditional Medicare beneficiaries.

For more data and analyses about Medicare and racial equity and health policy, visit kff.org

Cost-Related Problems Are Less Common Among Beneficiaries in Traditional Medicare Than in Medicare Advantage, Mainly Due to Supplemental Coverage

Published: Jun 25, 2021

Issue Brief

In recent years, the share of Medicare beneficiaries enrolled in Medicare Advantage, the private health plan alternative to the traditional Medicare program, has grown substantially. In 2021, 42% of all Medicare beneficiaries were enrolled in Medicare Advantage, up from 24% a decade earlier, with higher enrollment among some subgroups of beneficiaries than others. In 2018, half of all Black and Hispanic beneficiaries were enrolled in a Medicare Advantage plan, compared to 36% of White beneficiaries.

Given these shifts in enrollment and broader concerns about health inequities among Medicare beneficiaries, this analysis builds on our prior work examining rates of health care cost-related problems among Medicare beneficiaries, taking a closer look at cost-related problems among beneficiaries in traditional Medicare, including those with and without supplemental coverage, compared to those in Medicare Advantage, with a focus on equity.

Our analysis uses data from the 2018 Medicare Current Beneficiary Survey (MCBS) to examine the share of non-institutionalized Medicare beneficiaries reporting at least one of the following: trouble getting care due to cost or money, delay in care due to cost, or problems paying medical bills. All estimates reported in the text are statistically significant in bivariate (i.e., tabulations) and multivariate (i.e., based on a regression) analyses, except where noted. The multivariate analysis controls for income, race and ethnicity, and health status (see Methods). Due to sample size and data collection limitations, we were unable to analyze results by race and ethnicity for Asian adults, American Indian and Alaska Native adults, and Native Hawaiian and Other Pacific Islander adults, as well as certain subgroups of Hispanic adults.

Key findings include:

  • Overall, about one in six Medicare beneficiaries (17%) reported a cost-related problem in 2018, with a somewhat lower rate among traditional Medicare beneficiaries (15%) than Medicare Advantage enrollees (19%), attributable to a lower rate of cost-related problems among the majority of traditional Medicare beneficiaries with supplemental coverage (12%) (Figure 1, Table 1). The rate of cost-related problems is highest (30%) among traditional Medicare beneficiaries without supplemental coverage, who account for about 10 percent of the Medicare population.
  • A smaller share of Black beneficiaries in traditional Medicare (24%) than in Medicare Advantage (32%) reported cost-related problems. Rates of cost-related problems were lower among Black beneficiaries in traditional Medicare with Medicaid and other forms of supplemental insurance (20%).
  • One in five Hispanic beneficiaries overall reported a cost related problem (21%) and the share was similar among those in traditional Medicare with supplemental coverage (18%) and Medicare Advantage (22%).
  • The share of Black Medicare beneficiaries reporting cost-related problems was higher than among White beneficiaries in both traditional Medicare and Medicare Advantage. Additionally, the difference in the share of Black beneficiaries reporting cost-related problems in Medicare Advantage compared to traditional Medicare with supplemental coverage was larger than for White beneficiaries.
  • Half of Black Medicare Advantage enrollees in fair or poor self-assessed health reported cost-related problems, compared to one-third of Black beneficiaries in traditional Medicare overall and just over one-fourth of Black beneficiaries in traditional Medicare with supplemental coverage.
Figure 1: A Smaller Share of Beneficiaries in Traditional Medicare Than in Medicare Advantage Report Cost-Related Problems, Mainly Due to Supplemental Coverage

Findings

Overall, 17% of all Medicare beneficiaries living in the community reported health care cost-related problems in 2018. The rate of cost-related problems was twice as high among Black beneficiaries compared to White beneficiaries (28% vs. 14%), three times higher among beneficiaries in fair or poor self-reported health than among those in excellent, very good, or good self-reported health (34% vs. 11%), and 3.5 times higher among beneficiaries under age 65 with long-term disabilities than among those ages 65 and older (42% vs. 12%). Additionally, a larger share of Hispanic beneficiaries than White beneficiaries reported cost-related problems (21% vs. 14%), but the difference did not hold in multivariate analyses. As previously documented, cost-related problems were more common among lower-income Medicare beneficiaries with per capita income below $20,000 (27%) than beneficiaries with incomes at or above $40,000 (8%) (Table 1).

The rate of cost-related problems was somewhat lower among beneficiaries in traditional Medicare (15%) than among those enrolled in Medicare Advantage (19%), reflecting a lower rate among traditional Medicare beneficiaries with supplemental coverage (12%). Over 80% of traditional Medicare beneficiaries have supplemental coverage, such as employer-sponsored retiree health coverage, self-purchased Medigap policies, or Medicaid. However, among the roughly one in five people covered under traditional Medicare with no supplemental coverage – more than 5 million beneficiaries – 30% reported cost-related problems (Figure 1, Table 1). The differences across coverage types were significant after controlling for demographics, including income, and health status indicators.

Among lower-income Medicare beneficiaries (those with annual per capita income below $20,000), rates of cost-related problems were less common among traditional Medicare beneficiaries with supplemental coverage (primarily from Medicaid) than among traditional Medicare beneficiaries with no supplemental coverage and Medicare Advantage enrollees in the multivariate model. Among modest- and higher-income beneficiaries, a somewhat smaller share of traditional Medicare beneficiaries than Medicare Advantage enrollees reported cost-related problems, likely driven by the prevalence of supplemental coverage, such as Medigap or retiree health benefits, particularly among beneficiaries with per capita incomes over $40,000 (Table 1).

Rates of cost-related problems were lower among Black beneficiaries in traditional Medicare than among Black Medicare Advantage enrollees. A smaller share of Black traditional Medicare beneficiaries (24%) than Black Medicare Advantage enrollees (32%) reported cost-related problems, with the subset of Black traditional Medicare beneficiaries with supplemental coverage reporting the lowest rates of cost-related problems (20%). Differences in the rates of cost-related problems between Medicare Advantage and traditional Medicare were larger for Black beneficiaries than for White beneficiaries. The majority of Black beneficiaries in traditional Medicare have some form of supplemental coverage, primarily from Medicaid, but overall, 22% of Black beneficiaries in traditional Medicare have no supplemental coverage, versus 15% of White beneficiaries in traditional Medicare, based on our analysis of the 2018 MCBS.

Hispanic beneficiaries reported similar rates of cost-related problems in traditional Medicare with supplemental coverage and Medicare Advantage. About one in five (21%) Hispanic beneficiaries overall reported a cost-related problem. We did not detect a statistically significant difference in the share of Hispanic beneficiaries with a cost-related problem between those in traditional Medicare with supplemental coverage (18%) and those in Medicare Advantage (22%).

Among beneficiaries covered by either traditional Medicare or Medicare Advantage, Black Medicare beneficiaries reported higher rates of cost-related problems than White beneficiaries. The share of Black Medicare Advantage enrollees who reported a cost-related problem (32%) was twice as large as the share of White Medicare Advantage enrollees (16%) who reported a cost-related problem. Among traditional Medicare beneficiaries with supplemental coverage, the share of Black beneficiaries who reported a cost-related problem (20%) was also twice as large as the share of White traditional Medicare beneficiaries who reported a cost-related problem (10%). Hispanic beneficiaries had higher rates of cost-related problems than White beneficiaries in both traditional Medicare and Medicare Advantage based on bivariate analyses; however, differences did not hold in multivariate analyses controlling for demographic factors and health status.

Beneficiaries in fair or poor self-assessed health reported a higher rate of cost-related problems in Medicare Advantage than in traditional Medicare overall. Overall, 39% of Medicare Advantage enrollees in fair or poor self-reported health experienced cost-related problems in 2018, compared to 31% of traditional Medicare beneficiaries overall, and about the same share (27%) of the subset of traditional Medicare beneficiaries with supplemental coverage (Figure 2, Table 1). Due to sample size limitations, we were unable to examine rates of cost-related problems among beneficiaries in fair/poor health in traditional Medicare without supplemental coverage.

The rate of cost-related problems was particularly high among Black Medicare Advantage enrollees in fair or poor health. Among Black beneficiaries in fair or poor self-reported health, half (50%) of Medicare Advantage enrollees experienced cost-related problems, compared to one-third (34%) of those in traditional Medicare overall, and just over one-fourth (27%) of those in traditional Medicare with supplemental coverage. Likewise, among White beneficiaries in fair or poor self-reported health, a larger share of Medicare Advantage enrollees reported cost-related problems (35%) than beneficiaries in traditional Medicare with supplemental coverage (25%). These findings were significant at the bivariate level; however, we were unable to generate reliable multivariate estimates for this subgroup of the Medicare population due to sample size limitations. Additionally, due to sample size limitations, we were unable to examine rates of cost-related problems among Hispanic beneficiaries in fair/poor health in traditional Medicare compared to Medicare Advantage.

Figure 2: Among Beneficiaries in Fair or Poor Health, A Smaller Share of Those in Traditional Medicare Than in Medicare Advantage Report Cost-Related Problems, Overall and Among Black Enrollees

A smaller share of beneficiaries under age 65 in traditional Medicare than in Medicare Advantage reported cost-related problems, overall and particularly among Black beneficiaries. Among Medicare beneficiaries who are under age 65 and qualify for Medicare because of a long-term disability, nearly half of Medicare Advantage enrollees (47%) reported a cost-related problem in 2018, compared to 39% of traditional Medicare beneficiaries overall, and 32% of traditional Medicare beneficiaries with supplemental coverage. Among Black Medicare beneficiaries who are under age 65 with disabilities, about half (49%) of those enrolled in Medicare Advantage reported a cost-related problem, nearly twice the rate reported among those covered by traditional Medicare overall (26%), and considerably higher than the rate reported among traditional Medicare beneficiaries with supplemental coverage (19%) (Figure 3, Table 1).

Among White Medicare beneficiaries under age 65, the rate of cost-related problems was higher among Medicare Advantage enrollees (48%) than among traditional Medicare beneficiaries with supplemental coverage (36%). In contrast to patterns observed for other findings, a larger share of White beneficiaries than Black beneficiaries in traditional Medicare who are under age 65 with disabilities reported cost-related problems, both overall (43% versus 26%) and among those with supplemental coverage (36% versus 19%). This may be because Black beneficiaries are more likely to be dually enrolled in Medicare and Medicaid, which provides relatively comprehensive supplemental coverage. These findings are significant at the bivariate level; however, we were unable to generate reliable multivariate estimates comparing cost-related problems by race for the subgroup of beneficiaries in fair or poor health by coverage type (i.e., Medicare Advantage and traditional Medicare) due to sample size limitations.

Figure 3: Among Beneficiaries Under Age 65, A Smaller Share of Those in Traditional Medicare Than in Medicare Advantage Report Cost-Related Problems, Overall and Among Black Enrollees

Conclusion

Our analysis finds that a slightly smaller share of traditional Medicare beneficiaries than enrollees in Medicare Advantage reported cost-related problems in 2018, mainly attributable to lower rates of cost-related problems reported by traditional Medicare beneficiaries with supplemental coverage. These findings hold for both White and Black beneficiaries, although among Black beneficiaries, rates of cost-related problems in all coverage groups are generally higher, and differences between Medicare Advantage and traditional Medicare with supplemental coverage are larger. Hispanic beneficiaries reported similar rates of cost-related problems in both traditional Medicare with supplemental coverage and Medicare Advantage. The rate of cost-related problems was highest among beneficiaries in traditional Medicare with no supplemental coverage, both overall and within racial and ethnic groups.

Differences in cost-related problems between people with Medicare Advantage and traditional Medicare with supplemental coverage are not fully explained by differences in the characteristics of beneficiaries, such as income and health status. Similarly, higher rates of cost-related problems among Black beneficiaries compared to White beneficiaries persist after controlling for income, health status, and demographic characteristics. This may reflect the fact that Black beneficiaries have fewer financial resources, including savings and home equity, than White beneficiaries. Savings and other assets can serve as an important safety net, providing resources from which to draw when faced with high or unexpected expenses, such as health care costs. In addition, Black beneficiaries have more inpatient admissions and emergency department visits than White beneficiaries, which may increase their liability for associated health care spending, contributing to a greater financial burden. Further, racism and inequities in other factors, such as access to transportation, access to health care, and other social determinants of health likely contribute to cost-related problems obtaining or paying for health care.

These findings may run counter to expectations, given that Medicare Advantage plans, unlike traditional Medicare, have an out-of-pocket limit for Medicare-covered services, may have reduced cost-sharing for Medicare-covered services and often include coverage of vision, hearing, and dental services. Additionally, most Medicare Advantage enrollees pay no premium beyond the monthly Part B premium required of all Medicare beneficiaries. In contrast, traditional Medicare beneficiaries typically pay premiums for Part D and supplemental coverage (Medigap or retiree health benefits).

However, Medicare Advantage plans, like traditional Medicare, generally impose cost-sharing requirements for covered services, subject to certain limits, such as daily copayments for inpatient hospital stays or coinsurance for physician administered drugs, which means that Medicare Advantage enrollees may incur thousands of dollars in out-of-pocket costs for covered benefits before reaching their plan’s maximum out-of-pocket limit. In contrast, the majority of traditional Medicare beneficiaries have supplemental coverage that covers some or most of their Medicare deductibles and cost-sharing requirements, helping to mitigate cost-related problems. For example, the most common Medigap plans cover nearly all cost sharing for Medicare-covered services. Medicaid and the Medicare Savings Programs provide wrap-around support for low-income beneficiaries in both traditional Medicare and Medicare Advantage, though many low income beneficiaries do not receive these benefits.

This analysis is consistent with both our prior analysis and other research documenting cost-related problems among Medicare beneficiaries, which also found larger shares of beneficiaries in Medicare Advantage plans reporting cost-related problems compared to those in traditional Medicare, driven in large part by supplemental coverage. Analysis that focused more narrowly on the specific question of problems paying medical bills also showed higher rates of problems among Medicare Advantage enrollees than among adults age 65 and over with either traditional Medicare and private supplemental coverage or a stand-alone private health insurance plan.

Although our analysis documents that a somewhat smaller share of traditional Medicare beneficiaries than Medicare Advantage enrollees experience cost-related problems, we are unable to estimate actual differences in average out-of-pocket spending between these two groups. The MCBS reports out-of-pocket spending for all Medicare beneficiaries, but it cannot be used to derive comparable and accurate estimates of spending for Medicare Advantage enrollees like it can for beneficiaries in traditional Medicare. This is because it is not possible to verify survey-reported events in the MCBS with administrative claims data for Medicare Advantage enrollees, as is done for beneficiaries in traditional Medicare. This has the effect of biasing downward survey-reported out-of-pocket spending amounts for Medicare Advantage enrollees compared to beneficiaries with traditional Medicare. It is not possible to determine whether observed differences between the two groups are real or due to underlying differences in the data collection, verification, and imputation process for out-of-pocket spending by beneficiaries in traditional Medicare and Medicare Advantage.

Cost-sharing requirements and gaps in the traditional Medicare benefit, including no annual out-of-pocket limit and no coverage for dental, vision, and hearing services, undermine the financial protection provided by Medicare, and more so for some groups of beneficiaries, most notably for those with no supplemental coverage. At the same time, our findings suggest that enrollees in Medicare Advantage do not generally receive greater protection against cost-related problems than beneficiaries in traditional Medicare with supplemental coverage, particularly for some enrollees, such as Black beneficiaries in relatively poor health, despite having an out-of-pocket cap and additional benefits.

As policymakers consider proposals to lower the age of Medicare eligibility to 60 and improve benefits for the current Medicare population, and as Medicare Advantage enrollment continues to grow, the relatively high rate of cost-related problems in Medicare Advantage and inequities in who faces cost-related problems warrant attention, as do the high rates of cost-related problems among people in traditional Medicare without supplemental coverage.

This work was supported in part by Arnold Ventures. We value our funders. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

Methods

This analysis is based on data from the Centers for Medicare & Medicaid Services’ Medicare Current Beneficiary Survey (MCBS), 2018 Survey File. The analysis includes beneficiaries enrolled in Part A and Part B for most months of the year and excludes those with Part A or Part B only and Medicare as a Secondary Payer for most months of the year. The analysis also excludes institutionalized beneficiaries since the analysis was based on questions asked of community residents only.

In this analysis, we define “cost-related problems” based on positive responses to any of the following four questions:

  • Since (12 months prior), have you had any trouble getting health care that you wanted or needed because the cost was too high?
  • Since (12 months prior), have you had any trouble getting health care that you wanted or needed because you did not have enough money?
  • Since (12 months prior), have you delayed seeking medical care because you were worried about the cost?
  • Since (12 months prior) have you had problems paying or were unable to pay any medical bills?

We used a bivariate analysis to assess differences in the share of beneficiaries reporting cost-related problems across groups. All numbers reported in the text, figures, and table are a result of this analysis and we indicate where differences were statistically significant at the 5% level.

To account for differences in demographic characteristics and health status of Medicare beneficiaries enrolled in Medicare Advantage, traditional Medicare with supplemental coverage, and traditional Medicare without supplemental coverage, we modeled the likelihood of reporting a cost-related problem using a multivariate logistic regression. Specifically, we estimate the following:

E[Yi] = g(X’β)

where g(·) is a logit link function; Y is equal to 1 if beneficiary i reported a cost-related problem, Xi is a vector of individual-level covariates, including coverage type (Medicare Advantage, traditional Medicare with supplemental coverage, and traditional Medicare without supplemental coverage), income, age category, race/ethnicity, self-reported health status, number of chronic conditions, whether a beneficiary had a cognitive impairment, number of limitations in activities of daily living, and Medicare-Medicaid dual status.

To further examine the relationship between cost-related problems and coverage types, we estimated the same model on subsets of the full sample, including those with Medicare Advantage, those in traditional Medicare with supplemental coverage, those with traditional Medicare without supplemental coverage, White beneficiaries, Black beneficiaries, Hispanic beneficiaries, beneficiaries with per capita income below $20,000, income $20,000-$39,999, and income $40,000 and above, beneficiaries in fair/poor health, and beneficiaries under the age of 65 with a long-term disability. Tables 2 to 6 provide the odds-ratios and confidence intervals from each of the models.

Due to sample size limitations (as estimated by power and sample size calculations), we do not report data on self-reported health status and age group among Medicare beneficiaries without supplemental coverage, or among Hispanic beneficiaries and other racial and ethnic groups by sources of coverage. Additionally, while the collection of race and ethnicity data in survey data has improved over time, sample size and other limitations hinder our ability to display results comparing the share of Medicare beneficiaries reporting cost-related problems for certain racial and ethnic groups or subgroups within certain racial and ethnic groups in our analysis, especially Asian adults, American Indian and Alaska Native adults, Native Hawaiian and Other Pacific Islander adults, and adults who identify as two more races. Throughout this brief, individuals of Hispanic origin may be of any race, but are classified as Hispanic for the analysis; all other groups are non-Hispanic.

Tables

Table 1: Composite Measure of Health Care Cost-Related Problems Among Medicare Beneficiaries, 2018
Table 2: Estimated Odds-Ratios from Multivariate Logistic Regression Model, Full Sample
Table 3. Estimated Odds Ratios from Multivariate Logistic Regression Model, Stratified By Race/Ethnicity
Table 4: Estimated Odds Ratios From Multivariate Logistic Regression Model, Subset To Beneficiaries In Self-Reported Fair/Poor Health
Table 5: Estimated Odds Ratios From Multivariate Logistic Regression Model, Subset To Beneficiaries Age Under 65
Table 6: Estimated Odds Ratios From Multivariate Logistic Regression Model, Subset To Beneficiaries by Per Capita Annual Income